RE:RE:RE:RE: RE:RepliCel applies to TSX-V to extend warrantsJC, yes that is the law regarding publicly traded companies. The the large position "insiders" for the most part are the CEO and Directors. Other large position shareholders that are not Directors but do have roles in the operation of Replicel: Kevin McElwee and Rolf Hoffmann. You can' t tell me that these people listed above don't have more information regarding the Arbitration and the Dermal Injector than us 25%ers. Obviously these people have more information, they run the company.
The other large position shareholder (14,896,107 shares) that is not part of this group is Jamie Mackay. I don't think it is a stretch that he may just have a little more ianformation than we do.
On May 8th more options granted:
Ben Austring: 250,000 Options granted
David Hall: 100,000 Options granted
Peter Lowry: 100,000 Options granted
Peter Lewis: 75,000 Options granted
Andrew Schutte: 500,000 Options granted
Kevin McElwee: 250,000 Options granted